Even using this strategy some patients (minority) do have issues with sleep for the first 1-2 days after each injection
Response timelines vary
Journal of Physiology-Paris, 87 (5), 313-327
Secondary endpoints included the proportion of participants achieving 5% and 10% body weight reduction, absolute weight change in kg, change in waist circumference, lipid parameters including total cholesterol, HDL, LDL, VLDL, triglycerides, and glycaemic variables such as HbA1c, fasting glucose, insulin, HOMA-IR, and -cell function
This guide reflects CMS Billing and Coding Articles A58995 and A56681 and the NCCI PTP edit schedule updated as of June 2026
Dose-specific weight loss outcomes for tirzepatide Source: SURMOUNT-1 trial (Jastreboff et al., NEJM 2022)